Tranexamic Acid Injection

[Indications] It is suitable for the prevention and treatment of bleeding caused by systemic or local hyperfibrinolysis, including bleeding associated with surgery, trauma, abnormal uterine bleeding, and other conditions requiring antifibrinolytic therapy.

[Usage and dosage] This product is administered by intravenous injection or intravenous infusion. The usual adult dose is 0.25–0.5 g per administration, given 1–2 times daily according to the patient's condition. For surgical bleeding prevention and treatment, the dose and duration should be adjusted according to the type of surgery and bleeding severity. Intravenous administration should be performed slowly, and the dose should be adjusted in patients with renal impairment.